State Street SPDR Portfolio S&P 500 Growth ETF Vs. BridgeBio Pharma, Inc. Industry Stock Comparison

Buy

64

SPYG
State Street SPDR Portfolio S&P 500 Growth ETF

Last Price:

$99.24

Seasonality Move:

3.14%

Buy

51

BBIO
BridgeBio Pharma, Inc.

Last Price:

$73.17

Seasonality Move:

5.25%

Buy

64

State Street SPDR Portfolio S&P 500 Growth ETF (SPYG) is a Buy

Is State Street SPDR Portfolio S&P 500 Growth ETF a Buy, Sell or Hold?

The current State Street SPDR Portfolio S&P 500 Growth ETF [SPYG] share price is $99.26. The Score for SPYG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
SPYG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

51

BridgeBio Pharma, Inc. (BBIO) is a Buy

Is BridgeBio Pharma, Inc. a Buy, Sell or Hold?

The current BridgeBio Pharma, Inc. [BBIO] share price is $73.15. The Score for BBIO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SPYG Stock Price Chart

What is State Street SPDR Portfolio S&P 500 Growth ETF's stock price today?

The State Street SPDR Portfolio S&P 500 Growth ETF share price today is $99.26

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPYG is experiencing buying pressure, which is a positive indicator for future bullish movement.

BBIO Stock Price Chart

What is BridgeBio Pharma, Inc.'s stock price today?

The BridgeBio Pharma, Inc. share price today is $73.15

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing slight selling pressure.

SPYG Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.69	Sell
Relative Strength Index (14 RSI):	46	Sell
Chaikin Money Flow:	3525344	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(98.07 - 103.63)	Sell
Bollinger Bands (100):	(101.76 - 107.86)	Sell

BBIO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.66	Buy
Relative Strength Index (14 RSI):	55.21	Buy
Chaikin Money Flow:	-128497	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(66.58 - 72.4)	Buy
Bollinger Bands (100):	(67.73 - 76.59)	Buy

SPYG Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	97.62	Buy
20-day SMA:	100.18	Sell
50-day SMA:	103.16	Sell
200-day SMA:	102.72	Sell
8-day EMA:	98.27	Buy
20-day EMA:	99.77	Sell
50-day EMA:	102.18	Sell
200-day EMA:	100.92	Sell

BBIO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	71.71	Buy
20-day SMA:	70.4	Buy
50-day SMA:	71.53	Buy
200-day SMA:	61.39	Buy
8-day EMA:	72.08	Buy
20-day EMA:	70.93	Buy
50-day EMA:	70.94	Buy
200-day EMA:	62.01	Buy

State Street SPDR Portfolio S&P 500 Growth ETF Earnings Growth & SPYG Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BridgeBio Pharma, Inc. Earnings Growth & BBIO Earnings Dates

Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.26 per share, an increase this year of $1.05 per share, and an increase next year of $2.15 per share.

State Street SPDR Portfolio S&P 500 Growth ETF Technical Analysis

	Mar 20	Mar 23	Mar 24	Mar 25	Mar 26	Mar 27	Mar 30	Mar 31	Apr 1	Apr 2
	Mar									Apr
	20	23	24	25	26	27	30	31	01	02
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BridgeBio Pharma, Inc. Technical Analysis

	Mar 20	Mar 23	Mar 24	Mar 25	Mar 26	Mar 27	Mar 30	Mar 31	Apr 1	Apr 2
	Mar									Apr
	20	23	24	25	26	27	30	31	01	02
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):